Robert Tucker

发表

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Jennifer A. Johnson, J. Goudsmit, D. Barouch, 2013, The Journal of infectious diseases.

Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia

M. Klompas, J. Pearson, H. Moulton-Meissner, 2024, Open forum infectious diseases.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Jennifer A. Johnson, D. Barouch, M. Seaman, 2014, The Journal of infectious diseases.